Curi Bio

Seattle,  WA 
United States
  • Booth: 2302

Curi Bio’s preclinical platform integrates human iPSC-derived cells, tissue-specific biosystems, and AI/ML-enabled phenotypic screening data to accelerate the discovery of the next generation of medicines. Curi’s suite of human iPSC-derived products and services enable scientists to build more mature and predictive human iPSC-derived tissues—with a focus on cardiac, musculoskeletal, and neuromuscular models—for the discovery, safety testing, and efficacy testing of new drugs in development.

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".